The CHIPS Act and OSRA Create Positive Ripple Effects for the Trucking Industry

Last year, two major pieces of legislation passed that will be a huge boon to the trucking industry. The first is the CHIPS Act, which brings home the production of automotive and truck-grade chips. For context, the U.S.’s  semiconductor manufacturing share has drastically decreased from 37% in 1990 to 12% today.

The second piece of legislation is the Ocean Shipping Reform Act, which addresses the balance of power in the global supply chain. For over 100 years, the balance of power has been with ocean carriers, and the OSRA aims to rectify that and give more authority back to the trucking industry.

These legislative changes will have a significant impact on the trucking industry and the supply chain as a whole. Bill Sullivan, EVP of Advocacy for American Trucking Associations, and Weston Labar, Chief Spokesperson & SVP of Industry Relations for Cargomatic, offer further understanding of the critical nature of these bills and why they’re an optimistic sign for addressing long-standing challenges for U.S. trucking.

 

Bill & Weston’s Thoughts

B: “Last year became a year in which two really major legislative events happened for the trucking industry in different ways. In a year that nothing was supposed to move, major pieces of legislation moved last year, which was terrific. You know, if Congress is going to do stuff, we prefer they do good trucking policy.

So the two major legislative pieces that moved last year, just for those who don’t follow Congress every day, was the CHIPS Act, which was $52 billion, sort of the core piece of it was $52 billion of support to bring chip manufacturing back. The CHIPS Act does have a prioritization that includes automotive and truck-grade chips, so that was an important piece. And just as a country in terms of national policy, all of those being in Asia is a big problem.”

W: “I wanted to just underline how important that is for so many of the members of the APA, and especially for folks that are out here in states like California and some of the other states that then will follow the California environmental policies. This is a huge deal.”

B: “The other really important piece of legislation for trucking was the Ocean Shipping Reform Act, OSRA. And the beginning of the Biden administration had an executive order that talked about detention and demerge fees, a very long executive order, but recognized the challenges that the motor carrier industry, that the supply chain faces in the balance of activity, the balance of power, particularly in the intermodal space and in this global community and the global supply chain. So the balance of power has certainly been with ocean carriers for reasons that are understandable and go back more than 100 years.”

Article written by Adrienne St. Clair.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More